Apr
21
Two Stocks Stand Out In Red-Hot But Volatile Biotech Sector
ByThe enticing if volatile biotechs continue to intrigue investors. Some of the stocks in the fast-growing sector are more alluring than many others, but make no mistake: Biotechs should not be ignored!
“Biotech stocks are still in favor with investors for all the right reasons: constant M&A, solid clinical data, regulatory reviews, upcoming scientific conferences, selective stock picking, and technical support,” says veteran biotech analyst John McCamant, who is also editor of the Medical Technology Stock Letter, in Berkeley, California…
Two Stocks Stand Out In Red-Hot But Volatile Biotech Sector
